Skip to main content

Bausch & Lomb Corp(BLCO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume

Latest News

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
Business Wire - Mon Jan 23, 6:00AM CST
Business Wire
Mon Jan 23, 6:00AM CST
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2022 financial results on Wednesday, Feb. 22,...
Bausch + Lomb Acquires AcuFocus, Inc.
Business Wire - Tue Jan 17, 4:09PM CST
Business Wire
Tue Jan 17, 4:09PM CST
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and AcuFocus, Inc. (“AcuFocus”), a privately held ophthalmic medical device company, today...
Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™
Business Wire - Mon Jan 9, 7:00AM CST
Business Wire
Mon Jan 9, 7:00AM CST
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision ® AREDS 2 Formula mini soft gels with...
Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference
Business Wire - Mon Jan 9, 6:00AM CST
Business Wire
Mon Jan 9, 6:00AM CST
Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, has published a company update presentation designed to complement remarks...
Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference
Business Wire - Thu Jan 5, 6:00AM CST
Business Wire
Thu Jan 5, 6:00AM CST
Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chief executive officer, and Sam Eldessouky, executive...
Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology
Business Wire - Wed Jan 4, 6:00AM CST
Business Wire
Wed Jan 4, 6:00AM CST
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in class ocular...
Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month
Business Wire - Tue Jan 3, 6:00AM CST
Business Wire
Tue Jan 3, 6:00AM CST
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Glaucoma Research Foundation (GRF), a national non-profit organization with the vision of...
Why Bausch Health Stock Is Jumping Today
Motley Fool - Wed Sep 14, 2022
Motley Fool
Wed Sep 14, 2022
The company's exchange offer for existing senior notes appears to be going well.
Bausch + Lomb Corporation (BLCO) Q2 2022 Earnings Call Transcript
Motley Fool - Thu Aug 4, 2022
Motley Fool
Thu Aug 4, 2022
BLCO earnings call for the period ending June 30, 2022.
Why Bausch Health Stock Is Bolting Higher Today
Motley Fool - Fri Jun 24, 2022
Motley Fool
Fri Jun 24, 2022
An abrupt shake-up in the board of directors has investors piling into this healthcare stock today.